AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie long-Term Debt Maturities — Year 1 ($M) ($M)
Form 10-K Debt Note
Latest, FY2025
6,000
Period ended Dec 31, 2025
Change on a year earlier
-11.4%
6,771 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-Term Debt Maturities — Year 1 ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6,000 | -11.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 6,771 | -5.6% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 7,170 | +73.5% | Form 10-K (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 4,132 | -66.8% | Form 10-K (filed 2023-02-17) ↗ |
| FY2021 | Dec 31, 2021 | 12,428 | +47.6% | Form 10-K (filed 2022-02-18) ↗ |
| FY2020 | Dec 31, 2020 | 8,422 | +124.6% | Form 10-K (filed 2021-02-19) ↗ |
| FY2019 | Dec 31, 2019 | 3,750 | – | Form 10-K (filed 2020-02-21) ↗ |
Cite this data
StockData. (2026). AbbVie Long-Term Debt Maturities — Year 1 ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/debt_mat_y1
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.